Annual D&A:
$21.93M+$1.91M(+9.56%)Summary
- As of today, BEAM annual D&A is $21.93 million, with the most recent change of +$1.91 million (+9.56%) on December 31, 2024.
- During the last 3 years, BEAM annual D&A has risen by +$5.48 million (+33.36%).
- BEAM annual D&A is now -2.89% below its all-time high of $22.58 million, reached on December 31, 2022.
Performance
BEAM Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$5.54M+$10.00K(+0.18%)Summary
- As of today, BEAM quarterly D&A is $5.54 million, with the most recent change of +$10.00 thousand (+0.18%) on June 30, 2025.
- Over the past year, BEAM quarterly D&A has dropped by -$38.00 thousand (-0.68%).
- BEAM quarterly D&A is now -25.91% below its all-time high of $7.47 million, reached on September 30, 2023.
Performance
BEAM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$21.98M-$38.00K(-0.17%)Summary
- As of today, BEAM TTM D&A is $21.98 million, with the most recent change of -$38.00 thousand (-0.17%) on June 30, 2025.
- Over the past year, BEAM TTM D&A has increased by +$5.26 million (+31.43%).
- BEAM TTM D&A is now -21.22% below its all-time high of $27.90 million, reached on September 30, 2023.
Performance
BEAM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BEAM Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +9.6% | -0.7% | +31.4% |
| 3Y3 Years | +33.4% | +0.4% | +12.4% |
| 5Y5 Years | +305.5% | +154.3% | +161.3% |
BEAM Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -2.9% | +33.4% | -25.9% | +415.6% | -21.2% | +49.3% |
| 5Y | 5-Year | -2.9% | +305.5% | -25.9% | +415.6% | -21.2% | +161.3% |
| All-Time | All-Time | -2.9% | >+9999.0% | -25.9% | +415.6% | -21.2% | +4024.6% |
BEAM Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $5.54M(+0.2%) | $21.98M(-0.2%) |
| Mar 2025 | - | $5.53M(+1.6%) | $22.02M(+0.4%) |
| Dec 2024 | $21.93M(+9.6%) | $5.44M(-0.6%) | $21.93M(+48.9%) |
| Sep 2024 | - | $5.47M(-1.8%) | $14.73M(-12.0%) |
| Jun 2024 | - | $5.58M(+2.7%) | $16.73M(-9.3%) |
| Mar 2024 | - | $5.43M(+409.5%) | $18.44M(-7.8%) |
| Dec 2023 | $20.01M(-11.4%) | -$1.75M(-123.5%) | $20.01M(-28.3%) |
| Sep 2023 | - | $7.47M(+2.5%) | $27.90M(+7.1%) |
| Jun 2023 | - | $7.29M(+4.1%) | $26.05M(+7.3%) |
| Mar 2023 | - | $7.00M(+14.1%) | $24.27M(+7.5%) |
| Dec 2022 | $22.58M(+37.3%) | $6.14M(+9.3%) | $22.58M(+6.1%) |
| Sep 2022 | - | $5.62M(+1.8%) | $21.28M(+8.8%) |
| Jun 2022 | - | $5.51M(+3.9%) | $19.56M(+8.7%) |
| Mar 2022 | - | $5.31M(+9.6%) | $17.99M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $16.44M(+73.6%) | $4.84M(+24.3%) | $16.44M(+13.1%) |
| Sep 2021 | - | $3.90M(-1.2%) | $14.54M(+12.4%) |
| Jun 2021 | - | $3.94M(+5.0%) | $12.94M(+15.8%) |
| Mar 2021 | - | $3.76M(+27.6%) | $11.18M(+18.0%) |
| Dec 2020 | $9.47M(+75.2%) | $2.94M(+28.1%) | $9.47M(+12.6%) |
| Sep 2020 | - | $2.30M(+5.5%) | $8.41M(+12.7%) |
| Jun 2020 | - | $2.18M(+6.1%) | $7.47M(+14.5%) |
| Mar 2020 | - | $2.05M(+8.7%) | $6.52M(+20.5%) |
| Dec 2019 | $5.41M(+731.8%) | $1.89M(+39.9%) | $5.41M(+33.4%) |
| Sep 2019 | - | $1.35M(+9.7%) | $4.05M(+49.9%) |
| Jun 2019 | - | $1.23M(+30.7%) | $2.70M(+83.4%) |
| Mar 2019 | - | $941.00K(+76.5%) | $1.47M(+176.5%) |
| Dec 2018 | $650.00K(+5809.1%) | $533.00K | $533.00K |
| Dec 2017 | $11.00K | - | - |
FAQ
- What is Beam Therapeutics Inc. annual D&A?
- What is the all-time high annual D&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. annual D&A year-on-year change?
- What is Beam Therapeutics Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. quarterly D&A year-on-year change?
- What is Beam Therapeutics Inc. TTM D&A?
- What is the all-time high TTM D&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. TTM D&A year-on-year change?
What is Beam Therapeutics Inc. annual D&A?
The current annual D&A of BEAM is $21.93M
What is the all-time high annual D&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high annual D&A is $22.58M
What is Beam Therapeutics Inc. annual D&A year-on-year change?
Over the past year, BEAM annual D&A has changed by +$1.91M (+9.56%)
What is Beam Therapeutics Inc. quarterly D&A?
The current quarterly D&A of BEAM is $5.54M
What is the all-time high quarterly D&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high quarterly D&A is $7.47M
What is Beam Therapeutics Inc. quarterly D&A year-on-year change?
Over the past year, BEAM quarterly D&A has changed by -$38.00K (-0.68%)
What is Beam Therapeutics Inc. TTM D&A?
The current TTM D&A of BEAM is $21.98M
What is the all-time high TTM D&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high TTM D&A is $27.90M
What is Beam Therapeutics Inc. TTM D&A year-on-year change?
Over the past year, BEAM TTM D&A has changed by +$5.26M (+31.43%)